Boothbay Fund Management »

Oruka Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 68k 49.05
2025-06-30 $213k 19k 11.21
2025-03-31 $550k 54k 10.26

More positions owned by Boothbay Fund Management

At&t Call Option (T)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Call Option (TSLA)
Abivax Sa Sponsored Ads (ABVX)
Ge Aerospace Com New Call Option (GE)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Cornerstone Strategic Value (CLM)
Mineralys Therapeutics Put Option (MLYS)
United Therapeutics Corporation Call Option (UTHR)
Constellation Brands Cl A Call Option (STZ)

View all positions for Boothbay Fund Management

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
BlackRock
Viking Global Investors
Vanguard Group
Paradigm Biocapital Advisors
Rtw Investments
Deep Track Capital
Vanguard Capital Management
Remedium Capital Partners
Perceptive Advisors
State Street Corporation
venBio Select Advisor
Citadel Advisors

View all funds holding Oruka Therapeutics